Clinical Trial Update: Intravenous Autologous Bone Marrow-derived Stem Cells Therapy for Patients With Acute Ischemic Stroke [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of intravenous autologous bone marrow-derived stem cell therapy for acute ischemic stroke has completed the study. The sponsor is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Intravenous autologous bone marrow-derived stem cells therapy (autologous bone marrow-derived stem cells)

Snippet

Sponsor: Manipal Acunova Ltd. | Conditions: Acute Stroke | Phase 2 | Status: COMPLETED